RFK Jr. Responds to Family Members’ Criticism Over Trump Endorsement

Independent presidential candidate Robert F. Kennedy Jr. on Sunday responded to criticism from members of his family over his support for former President Donald Trump.

Last week, Kennedy announced he would be suspending his presidential campaign but would remain on the ballot in states that wouldn’t be competitive for either Trump or the Democratic Party’s nominee for president, Vice President Kamala Harris. He then appeared alongside Trump at an Arizona rally after announcing he would be endorsing the former president.

Kennedy on Sunday faced questions during a “Fox News Sunday” interview about a letter issued by several members of his family, who condemned his public support of Trump, that was distributed heavily on social media over the past weekend.

Read Full Article Here
 

Follow us

Read our latest news on any of these social networks!

Get latest news delivered daily!

We will send you breaking news right to your inbox


Have a tip? Let us know!

Recent Articles

  • by:
  • Source: Fox News
  • 03/14/2025
...
Chuck Schumer will vote to keep government open: 'For Donald Trump, a shutdown would be a gift'

Senate Minority Leader Chuck Schumer, D-N.Y., says he will vote to keep the government open, warning that a shutdown has worse consequences for Americans and would only empower President Donald Trump and Elon Musk further.

...
More than 2,000 laid off at Johns Hopkins University amid Trump budget cuts

Johns Hopkins University announced Thursday it's laying off over 2,000 employees amid budget cuts made by the Trump administration.

...
ICE: US Immigration Detention Maxed at 47.6K Detainees

U.S. immigration detention is filled to capacity at 47,600 detainees, a senior U.S. Immigration and Customs Enforcement official said on a call with reporters on Wednesday, adding that the Trump administration was seeking more bed space.

...
Yearly HIV prevention injection 'Lenacapavir' shows promise in clinical trial

Pain at the injection site was the most common adverse event, which was generally mild, resolved within one week.